Why the study?
Are heart rate variability techniques sensitive enough to define relevant clinical interactions between neural tone and mediators of vascular occlusion in atherosclerotic vascular disease?
Are heart rate variability techniques sensitive enough to define relevant clinical interactions between neural tone and mediators of vascular occlusion in atherosclerotic vascular disease?
This review explores whether heart rate variability is a sufficiently sensitive marker to assess the interaction between autonomic tone and mediators of vascular occlusion in coronary disease.
HRV sensitivity for autonomic-vascular interactions in CAD remains unproven; leaves open need for prospective validation before clinical adoption.
Many lines of experimental evidence suggest the interplay of the autonomic nervous system and a variety of mediators of vascular atheroma and ultimately vascular occlusion. In vivo study in human volunteers and patients is hampered by the lack of a reliable and sensitive marker of prevailing autonomic tone able to reflect the appropriate dynamic change in nervous activity. Currently, the modern standard for definition of autonomic tone is based on a variety of analyses of R-R interval variability from the surface ECG. In this review, we consider whether heart rate variability techniques are sensitive enough to define relevant clinical interactions between neural tone and other mediators of vascular occlusion--specifically, mechanical pressure, thrombotic and hormonal factors--which are relevant to atherosclerotic vascular disease.
No takes yet. Share an insight, caveat, or question.
Hamaad et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: